Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SGMT

Sagiment Biosciences (SGMT)

Sagiment Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SGMT
DateTimeSourceHeadlineSymbolCompany
06/13/20245:07AMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:SGMTSagiment Biosciences Inc
06/07/20243:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
06/07/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
06/06/20245:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
05/23/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
05/15/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
05/15/20246:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SGMTSagiment Biosciences Inc
05/08/20243:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
05/08/20243:05PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
05/06/20247:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
03/25/20246:00AMGlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:SGMTSagiment Biosciences Inc
03/25/20245:15AMGlobeNewswire Inc.Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SGMTSagiment Biosciences Inc
02/29/20247:00AMGlobeNewswire Inc.Sagimet Biosciences to Participate in Two Upcoming Investor ConferencesNASDAQ:SGMTSagiment Biosciences Inc
02/14/20245:10PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SGMTSagiment Biosciences Inc
02/14/20243:37PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SGMTSagiment Biosciences Inc
02/05/20243:34PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SGMTSagiment Biosciences Inc
02/02/20243:36PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
02/02/20243:05PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
01/31/20243:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
01/31/20243:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
01/30/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
01/25/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SGMTSagiment Biosciences Inc
01/25/20247:58PMGlobeNewswire Inc.Sagimet Biosciences Announces Pricing of Public Offering of Series A Common StockNASDAQ:SGMTSagiment Biosciences Inc
01/24/20245:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
01/24/20245:08AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SGMTSagiment Biosciences Inc
01/23/20244:45PMGlobeNewswire Inc.Sagimet Biosciences Announces Proposed Public Offering of Series A Common StockNASDAQ:SGMTSagiment Biosciences Inc
01/23/20244:31PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SGMTSagiment Biosciences Inc
01/22/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
01/22/20246:00AMGlobeNewswire Inc.Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASHNASDAQ:SGMTSagiment Biosciences Inc
12/29/20233:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SGMT